1. Home
  2. MIST vs NAAS Comparison

MIST vs NAAS Comparison

Compare MIST & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • NAAS
  • Stock Information
  • Founded
  • MIST 2003
  • NAAS 2019
  • Country
  • MIST Canada
  • NAAS China
  • Employees
  • MIST N/A
  • NAAS N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • NAAS Other Specialty Stores
  • Sector
  • MIST Health Care
  • NAAS Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • NAAS Nasdaq
  • Market Cap
  • MIST 164.9M
  • NAAS 9.0M
  • IPO Year
  • MIST N/A
  • NAAS 2017
  • Fundamental
  • Price
  • MIST $1.87
  • NAAS $3.45
  • Analyst Decision
  • MIST Strong Buy
  • NAAS
  • Analyst Count
  • MIST 3
  • NAAS 0
  • Target Price
  • MIST $6.33
  • NAAS N/A
  • AVG Volume (30 Days)
  • MIST 1.5M
  • NAAS 74.6K
  • Earning Date
  • MIST 11-11-2025
  • NAAS 11-19-2025
  • Dividend Yield
  • MIST N/A
  • NAAS N/A
  • EPS Growth
  • MIST N/A
  • NAAS N/A
  • EPS
  • MIST N/A
  • NAAS N/A
  • Revenue
  • MIST N/A
  • NAAS $21,817,052.00
  • Revenue This Year
  • MIST N/A
  • NAAS $378.49
  • Revenue Next Year
  • MIST N/A
  • NAAS N/A
  • P/E Ratio
  • MIST N/A
  • NAAS N/A
  • Revenue Growth
  • MIST N/A
  • NAAS N/A
  • 52 Week Low
  • MIST $0.63
  • NAAS $1.96
  • 52 Week High
  • MIST $2.75
  • NAAS $55.84
  • Technical
  • Relative Strength Index (RSI)
  • MIST 43.30
  • NAAS 48.30
  • Support Level
  • MIST $1.85
  • NAAS $3.13
  • Resistance Level
  • MIST $2.14
  • NAAS $4.19
  • Average True Range (ATR)
  • MIST 0.11
  • NAAS 0.35
  • MACD
  • MIST -0.03
  • NAAS -0.06
  • Stochastic Oscillator
  • MIST 5.69
  • NAAS 41.04

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.

Share on Social Networks: